MET and breast carcinoma: We furthermore observed that MET+CD47+ circulating tumor cells (CTCs) are mostly found among the population of CD44-expressing circulating breast cancer stem cells and that the presence of these CD44+MET+CD47+ “triple positive” CTCs correlates with dismal survival and increased metastasis in a small cohort of metastatic luminal breast cancer patients [41].